抗TNF-α抗体英夫利昔单抗治疗难治性肠白塞病的疗效 - Suppr

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.

作者信息

Iwata Shigeru, Saito Kazuyoshi, Yamaoka Kunihiro, Tsujimura Shizuyo, Nawata Masao, Suzuki Katsunori, Tanaka Yoshiya

出版信息

Rheumatology (Oxford). 2009 Aug;48(8):1012-3. doi: 10.1093/rheumatology/kep126. Epub 2009 May 22.

DOI:10.1093/rheumatology/kep126

PMID:19465589

Abstract

摘要

相似文献

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.

Rheumatology (Oxford). 2009 Aug;48(8):1012-3. doi: 10.1093/rheumatology/kep126. Epub 2009 May 22.

Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet's disease.

Mod Rheumatol. 2011 Apr;21(2):184-91. doi: 10.1007/s10165-010-0370-y. Epub 2010 Nov 5.

Successful treatment of refractory Behçet's disease with the TNF-alpha blocker infliximab.

Iran J Immunol. 2009 Mar;6(1):55-8.

[Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication].

Ned Tijdschr Geneeskd. 2006 Apr 1;150(13):705-9.

Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis.

Br J Ophthalmol. 2010 Mar;94(3):269-70. doi: 10.1136/bjo.2009.176750.

Successful treatment of long-standing neuro-Behçet's disease with infliximab.

J Rheumatol. 2005 Jan;32(1):181-3.

Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease.

Dig Liver Dis. 2019 Jul;51(7):967-971. doi: 10.1016/j.dld.2018.10.024. Epub 2019 Feb 19.

Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.

Rheumatology (Oxford). 2014 Dec;53(12):2223-31. doi: 10.1093/rheumatology/keu266. Epub 2014 Jul 4.

Successful treatment of genital ulcers with infliximab in Behcet's disease.

Ann Rheum Dis. 2004 Jun;63(6):744-5. doi: 10.1136/ard.2003.010975.

Effect of infliximab on refractory uveitis in Behcet's disease.

Ann Pharmacother. 2004 May;38(5):901-2. doi: 10.1345/aph.1D361. Epub 2004 Mar 9.

引用本文的文献

Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet's disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study.

Korean J Intern Med. 2023 Sep;38(5):661-671. doi: 10.3904/kjim.2022.394. Epub 2023 Jul 26.

Successful treatment of a refractory intestinal Behcet's disease with an oncology history by Vedolizumab: a case report and literature review.

Front Immunol. 2023 May 23;14:1205046. doi: 10.3389/fimmu.2023.1205046. eCollection 2023.

Biologic treatments in Behçet's disease.

Eur J Rheumatol. 2021 Oct;8(4):217-222. doi: 10.5152/eurjrheum.2020.20138.

Poor prognostic factors in patients with newly diagnosed intestinal Adamantiades-Behçet's disease in the Shanghai Adamantiades-Behçet's disease database: a prospective cohort study.

Orphanet J Rare Dis. 2019 Nov 28;14(1):274. doi: 10.1186/s13023-019-1228-9.

Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet's disease.

Arthritis Res Ther. 2019 Jun 22;21(1):151. doi: 10.1186/s13075-019-1933-8.

Infliximab associated with life-threatening lung infection in a patient with Behcet disease with intestinal and hematopoietic system involvement: A case report.

Medicine (Baltimore). 2017 Dec;96(50):e9202. doi: 10.1097/MD.0000000000009202.

Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?

Yonsei Med J. 2016 Jan;57(1):22-32. doi: 10.3349/ymj.2016.57.1.22.

Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease.

Case Rep Rheumatol. 2015;2015:716138. doi: 10.1155/2015/716138. Epub 2015 Nov 2.

Gastrointestinal Behçet's disease: a review.

World J Gastroenterol. 2015 Apr 7;21(13):3801-12. doi: 10.3748/wjg.v21.i13.3801.

Anti-TNF-alpha therapy and systemic vasculitis.

Mediators Inflamm. 2014;2014:493593. doi: 10.1155/2014/493593. Epub 2014 Feb 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献